alzheimer-s-disease

Documents about alzheimer-s-disease

• Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures#120129Europe PMC
• (Alzheimer's) dementia in adults with Down syndrome in Germany: Administrative prevalence based on a claims data analysis#333045Europe PMC
• Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease.#223084NCBI PubMed Central
• Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer's Disease in Japanese Individuals: Analysis Based on J-ADNI Study.#420895NCBI PubMed Central
• Microbiota-Gut-Brain Axis in Neurodegenerative Diseases: The Role of Bacterial Amyloids#471980HAL (France)
• A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease.#154199NCBI PubMed Central
• Spatial proteomics of Alzheimer's disease-specific human microglial states.#9213NCBI PubMed Central
• Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later.#14806NCBI PubMed Central
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths#123231Europe PMC
• Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.#152129NCBI PubMed Central
• Stroke-induced gut microbiome dysbiosis accelerates Alzheimer's disease progression.#218977NCBI PubMed Central
• Precision pathways: optimising amyloid PET for sustainable Alzheimer's disease care.#235958NCBI PubMed Central
• Time Distributed Classification of Alzheimer's Disease on MRI Scans#261133AVESIS
• AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.#262849NCBI PubMed Central
• Mitochondrial dysfunction in Alzheimer's disease: connecting pathophysiology with neuroimaging.#281151NCBI PubMed Central
• Geometric brain signatures of Alzheimer's disease progression and subtypes#282967bioRxiv / medRxiv
• Alzheimer's Disease Pathologies Affect Dopaminergic Neural Mechanisms of Memory.#284861NCBI PubMed Central
• Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.#285318NCBI PubMed Central
• Genomic analyses reveal new insights into Alzheimer's disease#290747bioRxiv / medRxiv
• Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.#320384NCBI PubMed Central
• APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.#320442NCBI PubMed Central
• Association of sleep duration with Alzheimer's disease and cognition.#354869NCBI PubMed Central
• Advances in Tricyclic Compounds for the Treatment of Alzheimer's Disease.#380706NCBI PubMed Central
• Cell-type-directed network-correcting combination therapy for Alzheimer's disease.#388810NCBI PubMed Central
• Sex- and brain region-specific gene expression in Alzheimer's disease.#406403NCBI PubMed Central
• Gut immune system in the murine model of Alzheimer’s disease#408602IBISS
• Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer's disease therapy.#412131NCBI PubMed Central
• Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer's Disease.#422825NCBI PubMed Central
• Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology.#446347NCBI PubMed Central
• Assembling peptides for treating Alzheimer's disease: a supramolecular perspective.#613408NCBI PubMed Central
• Double shrinkage transfer causal learning: An application to alzheimer's disease.#636394NCBI PubMed Central
• Cell-type signatures of Alzheimer's disease shared across population groups.#645226NCBI PubMed Central
• Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer's Disease.#409200NCBI PubMed Central
• Noninvasive Brain Stimulation Techniques and Their Efficacy in Treating Cognition and Memory in Mild Cognitive Impairment and Alzheimer’s Disease—A Systematic Review#231264Europe PMC
• A high-throughput assay for monitoring and quantifying amyloid-β accumulation and clearance in Alzheimer's disease cell models#299040Research Online
• Recent Insights Into Alzheimer's Disease: Advances in Pathophysiology and Therapeutic Strategies#161229HAL (France)
• Real-world comparison of brain [<sup>18</sup>F]FDG-PET imaging with CSF Alzheimer's disease biomarkers in a tertiary memory clinic setting#205477Europe PMC
• The intrinsic connectivity between the default mode and dorsal attention networks is an independent fMRI biomarker of Alzheimer's disease pathology burden#370947HAL (France)
• History of hypertensive disorders of pregnancy and risk of Alzheimer's disease and vascular dementia.#170527NCBI PubMed Central
• An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.#174463NCBI PubMed Central
• Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer's Disease: a Systematic Review of Mechanistic Insights.#182307NCBI PubMed Central
• Blood - brain barrier breakdown and neurovascular unit failure in the progression of Alzheimer's disease.#193520NCBI PubMed Central
• A technical assessment of latent diffusion for Alzheimer's Disease progression.#1353NCBI PubMed Central
• Impacts of host genetics on gut microbiome composition in Alzheimer's disease.#3853NCBI PubMed Central
• Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles.#8942NCBI PubMed Central
• Classification of Alzheimer’s Disease Using Traditional Classifiers with Pre-Trained CNN#116236PhilArchive
• Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis.#125320NCBI PubMed Central
• TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathology.#150017NCBI PubMed Central
• Deletion of TNFR1 in astrocytes restores memory in aged Alzheimer's disease mice#151547bioRxiv / medRxiv
• Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change.#161815NCBI PubMed Central